Breakout Labs

Breakout Labs, founded in 2012 as part of the Thiel Foundation, is an incubator and venture fund that supports early-stage, deep science companies with radical and emerging technologies. The fund provides up to $350,000 in initial funding and extensive support for startups that are too speculative for traditional venture capitalists. Breakout Labs focuses on companies at the intersection of technology, biology, materials, and energy, aiming to transition groundbreaking scientific discoveries from the lab to the market​. Notable portfolio companies include SciBac, which targets antibiotic-resistant diseases through microbiome science, and Azitra, which leverages the skin’s microbiome to treat skin diseases. Other innovative investments include ZymoChem, which develops sustainable chemical production processes, and EpiBone, which grows custom bones using 3D imaging and stem cells​. Breakout Labs has a history of significant follow-on funding for its portfolio companies, totaling over $1 billion. This success underscores their commitment to supporting the entire lifecycle of their investments, from seed to scale. The team, led by Managing Partners Lindy Fishburne and Julia Moore, includes experts who provide strategic guidance and leverage a vast network of founders, corporate partners, and advisors.